Chong Lei

Dr. Chong Lei


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SZShouqiang Zhu
Shouqiang Zhu
CLChong Lei
Chong Lei
This study aimed to investigate the association between marital status and the prognosis of patients with metastatic breast cancer (MBC). Data of patients with MBC were obtained from the Surveillance, Epidemiology, and End Results (SEER) database. Patients were classified into married and unmarried groups. Kaplan–Meier analysis with the log-rank test was conducted to compare breast cancer-specific survival (BCSS) and overall survival (OS) between the groups. Univariable and multivariable Cox proportional models were used to determine whether marital status was independently associated with OS, and the Fine–Gray subdistribution hazard method was performed to determine whether marital status was independently associated with BCSS. In total, 16,513 patients with MBC were identified, including 8949 married (54.19%) and 7564 unmarried (45.81%) patients. The married patients were significantly younger [median age (interquartile range), 59.0 (50.0–68.0) vs. 63.0 (53.0–75.0); p < 0.001] and received more aggressive treatments, such as chemotherapy (p < 0.001) and surgery (p < 0.001), than the unmarried patients. Moreover, married patients had higher 5-year BCSS (42.64% vs. 33.17%, p < 0.0001) and OS (32.22% vs. 21.44%, p < 0.0001) rates. Multivariable analysis revealed that marital status was an independent prognostic factor, and married status was associated with a significant reduction in the risk of breast cancer-specific (sub-hazard ratio, 0.845; 95% confidence interval, 0.804–0.888; p < 0.001) and all-cause (hazard ratio, 0.810; 95% confidence interval, 0.777–0.844; p < 0.001) mortality. Unmarried patients had a 15.5% increased risk of breast cancer-specific mortality and a 19.0% increased risk of overall mortality compared with married patients with MBC. BCSS and OS were superior in married populations compared with unmarried populations in most subgroups. Marital status was an independent prognostic indicator for survival in patients with MBC and was associated with significant survival benefits.

21 September 2023 in Anesthesiology and Perioperative Science
Verified
Journal Article
Open access
PDF file
XTXuemiao Tang
Xuemiao Tang
JLJia Li
Jia Li
BYBo Yang
Bo Yang
CLChong Lei
Chong Lei
HDHailong Dong
Hailong Dong
Sleep disturbances are risk factors for postoperative delirium (POD), and sleep interventions have been proposed as potential preventive measures. However, the effectiveness of sleep interventions in preventing POD is uncertain. We performed a systematic literature search using the PubMed, Embase, and Cochrane Library databases from inception until December 24, 2022. We included randomized controlled trials on sleep interventions and POD in adult surgery patients. The screening of titles, abstracts, and full texts was performed independently by two reviewers. Another two reviewers independently performed the data extraction and assessed the risk of bias. Pooled-effect estimates were calculated with a random effect model. Our primary outcome was POD, which was assessed with the confusion assessment method (CAM), CAM for the intensive care unit (CAM-ICU), or other delirium assessment tools. We used trial sequential analysis to control for type I and II statistical errors. We also conducted prespecified subgroup analyses, according to the type of intervention, efficacy of the intervention on postoperative sleep, sample size, participant age, delirium assessment tool used, and the type of surgery. Data were obtained from 25 trials, including 4799 participants. Sleep interventions had a statistically significant difference in the incidence of POD (relative risk (RR) = 0.60; 95% confidence interval (CI), 0.46–0.77; I2 = 58%). Stratified analyses indicated that the beneficial effects of sleep interventions were evident in trials where the interventions promoted postoperative sleep (RR = 0.51; 95% CI, 0.36–0.71) as compared to trials that did not (RR = 1.01; 95% CI, 0.77–1.31) (p-value for interaction between subgroups = 0.004). Our primary analysis demonstrated that in adult patients following elective surgery, interventions that improved postoperative sleep, as compared to the standard care or placebo groups, were associated with a lower risk of POD. However, such evidences are limited by the heterogeneity among trials and the small sample sizes of some trials. Graphical Abstract

5 September 2022 in Stem Cells
Verified
Journal Article
Closed access
PDF file
TZTaoyuan Zhang
Taoyuan Zhang
LLLinhe Lu
Linhe Lu
MLMan Li
Man Li
DZDing Zhang
Ding Zhang
PYPeng Yu
Peng Yu
CLChong Lei
Chong Lei
Acute lung injury (ALI) accompanied with systemic inflammatory response is an important complication after cardiopulmonary bypass (CPB). Pyroptosis, which is induced by the secretion of inflammatory factors, has been implicated in ALI. However, recent studies have suggested that bone marrow mesenchymal stem cell-derived exosomes (BMMSC-Exo) can ameliorate ALI, but the mechanism is poorly understood. Therefore, we aim to examine the effects of BMMSC-Exo in CPB-induced ALI, and its underlying mechanism. CPB rat models (male Sprague-Dawley rats) were administered BMMSC-Exo intravenously before induction of ALI. Lung tissue, bronchoalveolar lavage fluid (BALF), and alveolar macrophage (AM) were collected after the treatments for further analysis, and rat AM NR8383 cells were used for in vitro study. HE staining was performed to detect macrophage infiltration. Western blot was used to detect related proteins expression. And ELISA assay was performed to investigate secretion of inflammatory factors. These results showed that BMMSC-Exo treatment ameliorated macrophage infiltration and oxidative stress, and downregulated expression of pyroptosis-related proteins, including NLRP3, cleaved caspase-1, and GSDMD-N, in the lung tissue and AM, as well as decreased the secretion of IL-18 and IL-1β in BALF. Moreover, BMMSC-Exo activated YAP/β-catenin signaling pathway. Overall, these findings of this study indicated that BMMSC-Exo suppressed CPB-induced pyroptosis in ALI by activating YAP/β-catenin axis, which could be a novel strategy for lung protection during CPB.

29 March 2024 in Nitric Oxide
Verified
Journal Article
Closed access
YYYun Yan
Yun Yan
NKNikolay Kamenshchikov
Nikolay Kamenshchikov
ZZZiyu Zheng
Ziyu Zheng
CLChong Lei
Chong Lei

13 March 2020 in medRxiv
Verified
Preprint
Open access
PDF file
CLChong Lei
Chong Lei
BSBinxiao Su
Binxiao Su
HDHailong Dong
Hailong Dong
ABAndrea Bellavia
Andrea Bellavia
RFRaffaele Di Fenza
Raffaele Di Fenza
CMCaio Cesar Araujo Morais
Caio Cesar Araujo Morais
Introduction: Severe acute respiratory syndrome (SARS-CoV-2) due to novel Coronavirus (2019-nCoV) related infection (COVID-19) is characterized by severe ventilation perfusion mismatch leading to refractory hypoxemia. To date, there is no specific treatment available for 2019-nCoV. Nitric oxide is a selective pulmonary vasodilator gas used as a rescue therapy in refractory hypoxemia due to acute respiratory distress syndrome (ARDS). In has also shown in-vitro and clinical evidence that inhaled nitric oxide gas (iNO) has antiviral activity against other strains of coronavirus. The primary aim of this study is to determine whether inhaled NO improves oxygenation in patients with hypoxic SARS-CoV2. This is a multicenter randomized controlled trial with 1:1 individual allocation. Patients will be blinded to the treatment.Methods and analysis: Intubated patients admitted to the intensive care unit with confirmed SARS-CoV-2 infection and severe hypoxemia will be randomized to receive inhalation of NO (treatment group) or not (control group). Treatment will be stopped when patients are free from hypoxemia for more than 24 hours. The primary outcome evaluates levels of oxygenation between the two groups at 48 hours. Secondary outcomes include rate of survival rate at 28 and 90 days in the two groups, time to resolution of severe hypoxemia, time to achieve negativity of SARS-CoV-2 RT-PCR tests.Ethics and dissemination: The study protocol has been approved by the Investigational Review Board of Xijing Hospital (Xi’an, China) and pending the Partners Human Research Committee (Boston, USA). Recruitment will start after approval of both IRBs and local IRBs at other enrolling centers. Results of this study will be published in scientific journals, presented at scientific meetings, reported through flyers and posters, and published on related website or media in combating against this widespread contagious diseases.Trial registration: Clinicaltrials.gov. NCT submittedStrengths and limitations of this study: — Supplementation with nitric oxide (NO) might improve oxygenation and survival of SARS-CoV-2 patients. — The antiviral activity of NO inhalation will be explored by measuring the time difference between the two groups to reach SARS-CoV-2 RT- PCR negativity. — The spread of the disease worldwide determines the geographic areas of study and the recruitment rate of patients.

15 May 2023 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
GLGang Luo
Gang Luo
LWLini Wang
Lini Wang
ZZZiyu Zheng
Ziyu Zheng
BGBaobao Gao
Baobao Gao
CLChong Lei
Chong Lei
Kidney renal clear cell carcinoma (KIRC) is a main subtype of kidney cancers. Cuproptosis and ferroptosis are correlated with immune infiltration and prognosis in tumors. However, the role of Cuproptosis-related Ferroptosis genes (CRFGs) in KIRC has rarely been fully understood. Therefore, we constructed a prognostic signature based on different expression of CRFGs in KIRC. All raw data of this study were extracted from public TCGA datasets. Cuproptosis and Ferroptosis genes were collected from the previous research. Finally, a total of 36 significantly different CRFGs were identified from TCGA–KIRC cohort. Six-gene signature (TRIB3, SLC2A3, PML, CD44, CDKN2A and MIOX) was identified by LASSO Cox regression based on the significantly different CRFGs. The CRFGs signature was correlated with worse overall survival and the AUC was 0.750. Functional enrichment indicated that CRFGs were mainly enriched in metabolism, drug resistance, tumor immunity pathways. Besides, the IC50 and immune checkpoint differentially expressed between different groups. The proposed 6-CRFGs signature is a promising biomarker to predict clinical outcomes and therapeutic responses for KIRC patient.